Eplerenone 100 mg daily
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Massachusetts General Hospital
Overview
Eplerenone 100 mg daily is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Eplerenone 100 mg daily clinical trials
Explore related
Medical disclaimer. This page summarizes research about Eplerenone 100 mg daily for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.